Q3 2025 13F Holders as of 30 Sep 2025
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
192,966,469
-
Total 13F shares
-
191,767,706
-
Share change
-
+1,001,024
-
Total reported value
-
$8,955,119,353
-
Put/Call ratio
-
36%
-
Price per share
-
$46.70
-
Number of holders
-
318
-
Value change
-
+$87,454,891
-
Number of buys
-
176
-
Number of sells
-
136
Institutional Holders of Revolution Medicines, Inc. - Common Stock, par value $0.0001 per share (RVMD) as of Q3 2025
As of 30 Sep 2025,
Revolution Medicines, Inc. - Common Stock, par value $0.0001 per share (RVMD) was held by
318 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
191,767,706 shares.
The largest 10 holders included
VANGUARD GROUP INC, FARALLON CAPITAL MANAGEMENT LLC, JANUS HENDERSON GROUP PLC, WELLINGTON MANAGEMENT GROUP LLP, BAKER BROS. ADVISORS LP, FMR LLC, BlackRock, Inc., Nextech Invest, Ltd., Paradigm Biocapital Advisors LP, and Bellevue Group AG.
This page lists
318
institutional shareholders reporting positions in this security
for the Q3 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.